Skip to main content

Alaattin Erkanli

Associate Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Hock Plaza Box 2721, Durham, NC 27710
Duke University Medical Center 2424, Erwin Road Suite 110 Hock Plaza Box 2721, Durham, NC 27710

Overview


Areas of research interests include Bayesian hierarchical models for longitudinal data, Bayesian optimal designs, finite mixtures and Mixtures of Dirichlet Processes, Markov transition models, nonparametrics smoothing and density estimation, survival analysis for recurrent-event data, biomarker selection and detecting early ovarian cancer.

Current Appointments & Affiliations


Associate Professor of Biostatistics & Bioinformatics · 2022 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics

Recent Publications


Evaluation of opioid requirements in mechanically ventilated patients taking buprenorphine/naloxone prior to admission.

Journal Article J Crit Care · February 2026 BACKGROUND: With limited data quantifying opioid requirements based on substance use history, including buprenorphine/naloxone use, optimal pain management for mechanically ventilated patients remains unknown. OBJECTIVE: To compare opioid requirements in m ... Full text Link to item Cite

The Impact of a Protocol on Equitable Labor and Delivery Substance Use Screening: A Retrospective Cohort Study.

Journal Article Am J Perinatol · December 29, 2025 The Society for Maternal-Fetal Medicine (SMFM), the American College of Obstetricians and Gynecologists (ACOG), and the American Society of Addiction Medicine (ASAM) jointly recommend universal substance use screening in pregnancy with a validated tool. Bi ... Full text Link to item Cite

Evaluation of efficacy and safety of sequential antibody drug conjugates (ADCs) in human epidermal growth factor 2 (HER2)-negative metastatic breast cancer.

Journal Article Breast Cancer Res Treat · December 2025 PURPOSE: Limited data is available assessing sequencing of antibody drug conjugates (ADCs) in patients with hormone receptor-positive (HR +), human epidermal growth factor 2 (HER2)-negative, HER2-low, and triple-negative metastatic breast cancer (MBC), inc ... Full text Link to item Cite
View All Publications

Recent Grants


PFAS exposure is detrimental to placental function and fetal development by disrupting mitochondrial function and metabolism

ResearchClinical Investigator · Awarded by National Institutes of Health · 2025 - 2029

Perinatal Per- and Polyfluoroalkyl Substances (PFAS) exposure and Immunotoxicity

ResearchStatistician · Awarded by National Institute of Environmental Health Sciences · 2023 - 2028

NCANDA Research Project Site: Duke

ResearchStatistician · Awarded by National Institute on Alcohol Abuse & Alcoholism · 2012 - 2027

View All Grants

Education, Training & Certifications


Carnegie Mellon University · 1991 Ph.D.